Glucose metabolism and insulin secretion in children with cyanotic congenital heart disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 10, 1997, Pages 1082-1084

  Lundell, K H ^a   Sabel, K G ^b   Eriksson, B O ^c   Mellgren, G ^a  

^a Department of Paediatrics   (Sweden)

^b Department of Paediatrics ^*  (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C peptide; Congenital heart disease; Glucose; Insulin; Metabolism

Indexed keywords

C PEPTIDE; CATECHOLAMINE; GLUCOSE; INSULIN;

ARTICLE; CARBOHYDRATE METABOLISM; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYANOSIS; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PRIORITY JOURNAL;

EID: 0030817988     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb14812.x     Document Type: Article

References (11)

1. Mehrizi A, Drash A. Growth disturbance in congenital heart disease. J Pediatr 1962; 61:418-29
2. Ehlers KH. Growth failure in association with congenital heart disease. Pediatr Ann 1978; 7: 35-55
3. Hait G, Corpus M, Lamarre FR, Yuan S-H, Kypson J, Cheng G. Alteration of glucose and insulin metabolism in congenital heart disease. Circulation 1972; 46: 333
4. Hait G, Gruskin AB, Paulsen EP. Insulin suppression in children with congestive heart failure. Pediatrics 1972; 50: 451-5
5. Gács G. Plasma glucose, insulin and free fatty acids in infants with congenital heart disease. Endocrinology 1976; 67: 85-9
6. Dzimiri N, Galal O, Moorji A, Bakr S, Abbag F, Fadley F, Almotrefi A. Regulation of sympathetic activity in children with various congenital heart disease. Pediatr Res 1995; 38: 55-60
7. Lundell K-H, Sabel K-G, Eriksson BO, Mellgren G. Glucose metabolism and insulin secretion in infants with symptomatic ventricular septal defect. Acta Paediatr Scand 1989; 78: 620-6
8. Keith JD, Rowe RD, Vlad P, editors. Heart diseases in infancy and childhood. 3rd ed. New York: Macmillan Publishing Co, 1978: 625
9. Ruffolo RR Jr, Nichols AJ, Hieble P. Minireview: Metabolic regulation by α1-and α2-adrenoreceptors. Life Sci 1991; 49: 171-83
10. Haffner CA, Kendall MJ. Metabolic effects of β2-agonists. J Clin Pharm Therapeut 1992; 17: 155-64
11. Kjeldsen SE, Rostrup M, Moan A, Mundal HH, Gjesdal K, Eide IK. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension. J Cardiovasc Pharmacol 1992; 20 Suppl 8: S32-S39